Final part of the Treaty with Fizer: REAL WORLD INTERNATIONAL ECONOMIC EVIDENCE OF THE COSAL
⏳ ተ𐍂𐌉ଓ𐌵𑀉ꤕ Ⴝ𐌳𐍅Ⴝ🎙
Continued
10 page
specified in Section 2.1, to the public on a regular basis or as needed
for health reasons and in accordance with Israeli law, or to prevent the Ministry of Health from storing and analysing such data, regardless of this agreement and publications
of them. Nothing in this Agreement prevents PFIZER from producing
public-data publications. All publications related to the Project recognize the role of the Ministry of Health and Pfizer in the project.
Not backing down from the general provisions of the foregoing, to the extent that PFIZER
and the Ministry of Health cannot agree on a joint publication within a reasonable time or if PFIZER or the Ministry of Health wish to make further publications of the data and
the results of this Agreement, in addition to the joint publication, each Party will provide
other Party with a copy of the publication for painted the number of days before the date
submissions for publication or public disclosure to review such material.
During the verification period, the other Party may contribute by making an actual
correct and request the removal of any links to
Confidential information from the proposed disclosure or publication. All
Disclosure and publications should contain explicit recognition of the other party, if only
such a Party objected to such recognition. To the extent that Parties cannot
to resolve issues related to publications, they bring these issues to the proper
discussion of faith between painted PFIZER and
Sharon Alroy-Preis, M.D., Master of Health, Master of Business Administration.
9.2 Publicity.
9.2.1 Parties will issue a press release or public announcement, either jointly or solo (in agreement) of the Agreement, including information on the Project, its timing and time after the effective date; When the content of such
The announcement is agreed by mutual agreement. All other public announcements (e.g.
Press Releases) in this Agreement are agreed upon and issued on time mutually agreed by the Parties, unless disclosure is required by law or is required to respond to requests by the state or federal regulators. A timely written notice should be sent to another Party if the Party is required to disclose such information. In the course of this Agreement, if any Party wishes to make a public announcement of this Agreement or programme, such a Party must notify in advance within a reasonable time, but in no case at least a day before the proposed text is notified to the other party
for its preliminary review and approval.
9.2.2 Except in the cases permitted by this Section, no Party may use corporate signs or
product name or other party's logo in any presentation, including
publications, news releases, promotional materials and other
public announcements, written or oral, without prior written
approval of the other side.
10. GENERAL
10.1 Relationship between the parties. PFIZER and the Ministry of Health recognize and agree that nothing is contained. this document is not intended to present them as an employer/employee, joint venture or partner, which is their intention that each Party will have an independent relationship with the other Party. PFIZER AND MOH
recognize and agree that the staff employed by each Party in connection with any work will perform in accordance with this Agreement, always remain staff or hired consultants of such
The Parties and such a Party are solely responsible for all aspects of the recruitment of such persons, including:
11 page
recruitment, dismissal, training, promotion, compensation, benefits, payroll taxes, severance pay and all other deductions or payments made by employers on behalf of or on behalf of employees.
10.2 Compliance with the law. The Ministry of Health and PFIZER must take all necessary and appropriate actions to ensure compliance with all regulatory requirements in the implementation of this Agreement. A hierarchy of terms. The terms and conditions of this Agreement apply to all applications or other annexes to this Agreement signed by the Parties that refer to this Agreement. In the event of any conflict between the terms of this Agreement and the terms of any such Annex or other annexes to this Agreement, the provisions of this Agreement take precedence. The terms of this Agreement and the applicable Annexes and other annexes to this Agreement must determine any terms of any endorsement of the sale, invoice or other similar documents issued by any of the Parties.
10.3 Non-exceptional.
Nothing in this Agreement should be construed as imposing any obligation of exclusivity on any Party: and any Party would have the right to work with other third parties in accordance with the terms of this Agreement, including, but not limited to, pharmaceutical companies in the development of programmes. and services similar to those outlined in this Agreement.
10.4 10.5 Agreement without the prior written consent of other Parties.
Any such attempt to transfer rights or delegation of responsibilities without the prior written consent of other Parties is invalid and ineffective. Any such assignment or delegation to which the Party has agreed does not absolve the other Party of its responsibility and obligations under this Agreement. Assign. Neither Party may cede its rights or obligations according to the data
10.6.
No modifications, amendments or amendments to this Agreement are binding on Parties unless they are contained in writing, signed by a properly authorized agent for each party concerned and specifically referring to the present or other Agreement.
10.7 Notices.
Any notification that is required to be sent in accordance with this document must be sent in writing and is considered to be sent: (a) when received, if delivered in person, (b) on the third working day after it is sent by mail, if mailed by certified first class mail, prepaid postal services, requested receipt, (c) the day after the night courier service or (d) on the day of the e-mail: provided, however, that in the case of the email the sender must make sure of the subsequent phone call to confirm receipt, if the recipient does not confirm receipt of the return email, in any case
The doctors' names and email addresses have been painted over.
Israeli Ministry of Health Attn: Dr 39 Yirmiyahu St. Jerusalem 9101002 Email: moh.gov.
il PFIZER INC.
Dr. Pfizer
Vaccines Medical 235 East 42nd Street New York. New York City, NY 10017
12 pages
PFIZER INC, Attn: General Counsel 235 East 42nd Street cc: New York, New York 10017 PFIZER or the Ministry of Health may, by sending a written notice to others, change the addresses and names mentioned above.
10.8 Binding Effect.
This Agreement is binding and acts in the interests of PFIZER and the Ministry of Health, their respective successors and eligible successors. Applied law. All disputes are governed by the laws of the State of New York, USA, without regard to the principles of conflict law, except that any dispute concerning arbiter's capacity or scope and application of this section must be governed by the Federal Arbitration Act. The United States.
10.9 10.10 Dispute Resolution.
Painted
13 page
10.11 Expenses.
Each of the Parties to this Agreement bears all the costs incurred by it in connection with the negotiations and preparation of this Agreement, as well as by the completion and preparation of the transactions under this Agreement, including, among other things, any taxes incurred in connection with the completion of the transactions. agreement.
10.12 Independent parties.
The parties to this Agreement are independent contractors involved in running their own business. No Party is and should not be considered as an agent or employee of the other party for any purpose. Neither Party has the right to enter into contracts or make any obligations to the other Party, nor does it have the right to make any guarantees or assurances on behalf of the other Party. Nothing in this Agreement can be construed as establishing partnerships or joint ventures between parties.
10.13 Third-party beneficiaries.
None of the provisions of this Agreement can be used in favour of a third party, including, among other things, any creditor of any other party. No such third party will receive any rights under any provision of this Agreement and will not, under any such provision, make any claim for any debt, obligation or obligation (or otherwise) against any of the Parties under this Agreement.
10.14 Analogs. The agreement can be signed in any number of copies, each of which for all purposes is considered the original, but together make the same document.
10.15 Position. If any part, conditions or provisions are declared unlawful or null and void, it will not affect the validity of the remaining parts or provisions of this Agreement, and the illegal or unenforceable parts of the Agreement will have the maximum legal effect. in accordance with the law. leaving the rest of this Agreement unchanged.
10.16 Headlines.
The headlines of sections of this Agreement are inserted for convenience and only for reference purposes, are non-binding and in no way define, restrict or describe the scope of this Agreement or the purpose of any section.
10.17 Electronic delivery and storage.
Delivery of the Signed Agreement through reliable electronic means of communication, including fax or e-mail (with the confirmation of the receipt), is an effective way of delivering the concluded Agreement. This Agreement may be electronically stored, and an original or electronically stored copy of this Agreement may be used for any purpose, including any procedure to ensure that the rights or obligations of the Parties under this Agreement are respected.
10.18 English.
This Agreement must be drafted and written in English, and all other communications under this Agreement or in connection with it will be carried out in English. Any translation into any other language is not its official version, and in the case of any conflict in interpretation between the English version and such a translation, the English version takes precedence. 10.19 Additional documents. Each Party agrees to issue such additional documents and accept them as reasonably necessary or desirable to meet the objectives of this Agreement. And so on
THIS PAGE IS INTENTIONALLY EMPTY.
15 page, the name of the person who signed this contract from Fiser is painted
In THE COSION WHAT, each of the parties to this Agreement has ensured the proper implementation of this Agreement on its own behalf and on its own behalf, all on the date above.
ISRAELI MINISTRY OF HEALTH
Prof. Chezi Levy. M.D., M.H.A.
Position: CEO of PFIZER INC.
Unknown, Pfizer Vaccines
Any contract has apps and they are in the next part of our material.